AlphaGalileo > Item Display alphagalileo.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alphagalileo.org Daily Mail and Mail on Sunday newspapers.
Electronic Data Capture Software Market to see Huge Growth by 2025 | Castor, Formedix, Medrio
iCrowd Newswire
The latest study released on the Global
Electronic Data Capture Software Market by AMA Research evaluates market size, trend, and forecast to 2026. The
Electronic Data Capture Software market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This Report Include:
IBM (United States),Fortress Medical (United States),Forte Research Systems (United States),Castor EDC (The Netherlands),Data MATRIX (United States),Medidata Solutions (United States),Dacima Software (Canada),Formedix (United Kingdom),Medrio (United States),Repnets Ltd. (United States) ,Anju Software (United States),DATATRAK (United States),Ar
Global
Electronic Data Capture Software Market valued approximately USD XX billion in 2017 and is anticipated to grow with a healthy growth rate of XX% over the forecast period 2018-2025. The Electronic Data Capture Software Market is continuously growing across the world over the coming years. Electronic Data Capture (EDC) leverages different systems, which slightly vary in terms of features and functionalities, to gather clinical trial data in electronic form. A software, it streamlines, and stores patient data accumulated during clinical trials. Data is either procured electronically or first recorded on paper and then transcribed into the system and saved in an electronic case report form (eCRF). Some of the basic features of an electronic data capture (EDC) are eCRF designer, query management, data entry, and data export. The Electronic Data Capture Software market is mainly driven owing to escalating demand for software solutions considering clinical trials, surging research
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Colchicine reduces the risk of COVID-19-related complications
Montreal Heart InstituteJanuary 23, 2021 GMT
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of COVID-19, c